Quince Therapeutics Competitors and Similar CompaniesClear all
Quince Therapeutics's competitors and similar companies include Alector, Vertex Pharmaceuticals, Livzon Pharmaceutical Group and CSL Behring.
 Quince Therapeutics Quince Therapeutics (formerly known as Cortexyme) is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2012 | Founding Date 2013 | Founding Date 1989 | Founding Date 1985 | Founding Date 1904 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Francisco, US HQ | Locations San Francisco, US HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | |
Employees | Employees 2321% increase | Employees 2382% decrease | Employees 5,40013% increase | Employees 9,067 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 51.1 m | Valuation ($) 495.3 m | Valuation ($) 121.4 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $12b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $10.4b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income ($84m) (FY, 2025) | Net income ($142.9m) (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Patent Applications | Patent Applications N/A | Patent Applications 380 (FY, 2021) | Patent Applications N/A | Patent Applications N/A | Patent Applications 3 (Dec, 2020) |
Trademark Applications | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 194.5m | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Alector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyVertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company